Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL OSTEOSYNTHESIS DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL OSTEOSYNTHESIS DEVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL OSTEOSYNTHESIS DEVICES MARKET : RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
5.3 SURGERIES/PROCEDURES IN VOLUMES
5.4 HOSPITALS AND UROLOGIST IN MIDDLE EAST REGION
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. INSTALLED BASE DATA
15. VALUE CHAIN ANALYSIS
16. HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
17. ECONOMIC DEVELOPMENT
18. GLOBAL OSTEOSYNTHESIS DEVICES MARKET, BY PRODUCT TYPE
18.1 OVERVIEW
18.2 INTERNAL DEVICES
18.2.1 SCREW
18.2.1.1. COMPRESSION BONE SCREWS
18.2.1.1.1. MARKET VALUE (USD MILLION)
18.2.1.1.2. MARKET VOLUME (UNITS)
18.2.1.1.3. AVERAGE SELLING PRICE (USD)
18.2.1.2. ARTHRODESIS SCREWS
18.2.1.2.1. MARKET VALUE (USD MILLION)
18.2.1.2.2. MARKET VOLUME (UNITS)
18.2.1.2.3. AVERAGE SELLING PRICE (USD)
18.2.1.3. BONE SCREW WASHERS
18.2.1.3.1. MARKET VALUE (USD MILLION)
18.2.1.3.2. MARKET VOLUME (UNITS)
18.2.1.3.3. AVERAGE SELLING PRICE (USD)
18.2.2 PLATES
18.2.2.1. COMPRESSION PLATES
18.2.2.1.1. MARKET VALUE (USD MILLION)
18.2.2.1.2. MARKET VOLUME (UNITS)
18.2.2.1.3. AVERAGE SELLING PRICE (USD)
18.2.2.2. OSTEOTOMY PLATES
18.2.2.2.1. MARKET VALUE (USD MILLION)
18.2.2.2.2. MARKET VOLUME (UNITS)
18.2.2.2.3. AVERAGE SELLING PRICE (USD)
18.2.2.3. ARTHRODESIS PLATES
18.2.2.3.1. MARKET VALUE (USD MILLION)
18.2.2.3.2. MARKET VOLUME (UNITS)
18.2.2.3.3. AVERAGE SELLING PRICE (USD)
18.2.3 STAPLES
18.2.3.1. MARKET VALUE (USD MILLION)
18.2.3.2. MARKET VOLUME (UNITS)
18.2.3.3. AVERAGE SELLING PRICE (USD)
18.2.4 NAILING
18.2.4.1. MARKET VALUE (USD MILLION)
18.2.4.2. MARKET VOLUME (UNITS)
18.2.4.3. AVERAGE SELLING PRICE (USD)
18.2.5 WIRES
18.2.5.1. MARKET VALUE (USD MILLION)
18.2.5.2. MARKET VOLUME (UNITS)
18.2.5.3. AVERAGE SELLING PRICE (USD)
18.2.6 RODS & PINS
18.2.6.1. MARKET VALUE (USD MILLION)
18.2.6.2. MARKET VOLUME (UNITS)
18.2.6.3. AVERAGE SELLING PRICE (USD)
18.2.7 ANCHORS
18.2.7.1. MARKET VALUE (USD MILLION)
18.2.7.2. MARKET VOLUME (UNITS)
18.2.7.3. AVERAGE SELLING PRICE (USD)
18.2.8 ORTHOPEDIC CABLE SYSTEM
18.2.8.1. MARKET VALUE (USD MILLION)
18.2.8.2. MARKET VOLUME (UNITS)
18.2.8.3. AVERAGE SELLING PRICE (USD)
18.2.9 OTHERS
18.3 EXTERNAL DEVICES
18.3.1 FRACTURE FIXATION
18.3.1.1. BY PRODUCT
18.3.1.1.1. KNEE BRIGDE FRAME
18.3.1.1.1.1 MARKET VALUE (USD MILLION)
18.3.1.1.1.2 MARKET VOLUME (UNITS)
18.3.1.1.1.3 AVERAGE SELLING PRICE (USD)
18.3.1.1.2. RING FIXATION SYSTEM
18.3.1.1.2.1 MARKET VALUE (USD MILLION)
18.3.1.1.2.2 MARKET VOLUME (UNITS)
18.3.1.1.2.3 AVERAGE SELLING PRICE (USD)
18.3.1.1.3. MULTI AXIAL CORRECTION SYSTEM
18.3.1.1.3.1 MARKET VALUE (USD MILLION)
18.3.1.1.3.2 MARKET VOLUME (UNITS)
18.3.1.1.3.3 AVERAGE SELLING PRICE (USD)
18.3.1.1.4. MINI FIXATOR
18.3.1.1.4.1 MARKET VALUE (USD MILLION)
18.3.1.1.4.2 MARKET VOLUME (UNITS)
18.3.1.1.4.3 AVERAGE SELLING PRICE (USD)
18.3.1.2. BY TYPE
18.3.1.2.1. UNILATERAL & BILATERAL EXTERNAL FIXATORS
18.3.1.2.1.1 MARKET VALUE (USD MILLION)
18.3.1.2.1.2 MARKET VOLUME (UNITS)
18.3.1.2.1.3 AVERAGE SELLING PRICE (USD)
18.3.1.2.2. CIRCULAR FIXATORS
18.3.1.2.2.1 MARKET VALUE (USD MILLION)
18.3.1.2.2.2 MARKET VOLUME (UNITS)
18.3.1.2.2.3 AVERAGE SELLING PRICE (USD)
18.3.1.2.3. HYBRID FIXATORS
18.3.1.2.3.1 MARKET VALUE (USD MILLION)
18.3.1.2.3.2 MARKET VOLUME (UNITS)
18.3.1.2.3.3 AVERAGE SELLING PRICE (USD)
18.3.1.2.4. OTHERS
18.3.2 BONE LENGTHENING
19. GLOBAL OSTEOSYNTHESIS DEVICES MARKET, BY MATERIAL
19.1 OVERVIEW
19.2 DEGRADABLE
19.2.1 OLYLACTIC ACID POLYMER
19.2.2 POLYGLYCOLIC ACID POLYMERS
19.2.3 OTHERS
19.3 NONDEGRADABLE
19.3.1 TITANIUM
19.3.2 STAINLESS STEEL
19.3.3 ALLOYS
19.3.4 OTHERS
20. GLOBAL OSTEOSYNTHESIS DEVICES MARKET, BY FRACTURE TYPE
20.1 OVERVIEW
20.2 SKULL
20.2.1 INTERNAL FIXATOR DEVICES
20.2.2 EXTERNAL FIXATOR DEVICES
20.3 FACIAL BONES
20.3.1 INTERNAL FIXATOR DEVICES
20.3.2 EXTERNAL FIXATOR DEVICES
20.4 STERNUM
20.4.1 INTERNAL FIXATOR DEVICES
20.4.2 EXTERNAL FIXATOR DEVICES
20.5 RIBS
20.5.1 INTERNAL FIXATOR DEVICES
20.5.2 EXTERNAL FIXATOR DEVICES
20.6 CLAVICLE, SCAPULA, AND HUMERUS
20.6.1 INTERNAL FIXATOR DEVICES
20.6.2 EXTERNAL FIXATOR DEVICES
20.7 RADIUS OR ULNA, AND BOTH
20.7.1 INTERNAL FIXATOR DEVICES
20.7.2 EXTERNAL FIXATOR DEVICES
20.8 WRIST
20.8.1 INTERNAL FIXATOR DEVICES
20.8.2 EXTERNAL FIXATOR DEVICES
20.9 VERTEBRAL COLUMN
20.9.1 INTERNAL FIXATOR DEVICES
20.9.2 EXTERNAL FIXATOR DEVICES
20.10 PELVIS
20.10.1 INTERNAL FIXATOR DEVICES
20.10.2 EXTERNAL FIXATOR DEVICES
20.11 HIP
20.11.1 INTERNAL FIXATOR DEVICES
20.11.2 EXTERNAL FIXATOR DEVICES
20.12 FEMUR
20.12.1 INTERNAL FIXATOR DEVICES
20.12.2 EXTERNAL FIXATOR DEVICES
20.13 PATELLA, TIBIA OR FIBULA
20.13.1 INTERNAL FIXATOR DEVICES
20.13.2 EXTERNAL FIXATOR DEVICES
20.14 FOOT BONES
20.14.1 INTERNAL FIXATOR DEVICES
20.14.2 EXTERNAL FIXATOR DEVICES
21. GLOBAL OSTEOSYNTHESIS DEVICES MARKET, BY SITE
21.1 OVERVIEW
21.2 LOWER EXTREMITIES
21.2.1 KNEE
21.2.2 FOOT AND ANKLE
21.2.3 HIP & PELVIC
21.2.4 LOWER LEG
21.2.5 THIGH
21.2.6 SPINE
21.3 UPPER EXTREMITIES
21.3.1 SHOULDER
21.3.2 HAND AND WRIST
21.3.3 ELBOW
21.3.4 ARM
21.3.5 OTHERS
22. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , BY PATIENT TYPE
22.1 OVERVIEW
22.2 PEDIATRIC
22.3 ADULTS
22.4 GERIATRICS
23. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , BY PATIENT TYPE
23.1 OVERVIEW
23.2 MALE
23.3 FEMALE
24. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , BY END USER
24.1 OVERVIEW
24.2 HOSPITALS
24.3 ORTHOPAEDIC CLINICS
24.4 AMBULATORY SURGICAL CENTERS
24.5 TRAUMA CENTERS
24.6 OTHERS
25. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , BY DISTRIBUTION CHANNEL
25.1 OVERVIEW
25.2 DIRECT TENDER
25.3 RETAIL SALES
25.3.1 ONLINE
25.3.2 OFFLINE
25.4 OTHERS
26. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , COMPANY LANDSCAPE
26.1 COMPANY SHARE ANALYSIS: GLOBAL
26.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
26.3 COMPANY SHARE ANALYSIS: EUROPE
26.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
26.5 MERGERS & ACQUISITIONS
26.6 NEW PRODUCT DEVELOPMENT & APPROVALS
26.7 EXPANSIONS
26.8 REGULATORY CHANGES
26.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
27. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , BY GEOGRAPHY
GLOBAL OSTEOSYNTHESIS DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
27.1 NORTH AMERICA
27.1.1 U.S.
27.1.2 CANADA
27.1.3 MEXICO
27.2 EUROPE
27.2.1 GERMANY
27.2.2 FRANCE
27.2.3 U.K.
27.2.4 HUNGARY
27.2.5 LITHUANIA
27.2.6 AUSTRIA
27.2.7 IRELAND
27.2.8 NORWAY
27.2.9 POLAND
27.2.10 ITALY
27.2.11 SPAIN
27.2.12 RUSSIA
27.2.13 TURKEY
27.2.14 NETHERLANDS
27.2.15 SWITZERLAND
27.2.16 REST OF EUROPE
27.3 ASIA-PACIFIC
27.3.1 JAPAN
27.3.2 CHINA
27.3.3 SOUTH KOREA
27.3.4 INDIA
27.3.5 AUSTRALIA
27.3.6 SINGAPORE
27.3.7 THAILAND
27.3.8 MALAYSIA
27.3.9 INDONESIA
27.3.10 PHILIPPINES
27.3.11 VIETNAM
27.3.12 REST OF ASIA-PACIFIC
27.4 SOUTH AMERICA
27.4.1 BRAZIL
27.4.2 ARGENTINA
27.4.3 CHILE
27.4.4 PERU
27.4.5 COLOMBIA
27.4.6 VENEZUELA
27.4.7 REST OF SOUTH AMERICA
27.5 MIDDLE EAST AND AFRICA
27.5.1 SOUTH AFRICA
27.5.2 SAUDI ARABIA
27.5.3 UAE
27.5.4 EGYPT
27.5.5 KUWAIT
27.5.6 ISRAEL
27.5.7 REST OF MIDDLE EAST AND AFRICA
27.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
28. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , SWOT AND DBMR ANALYSIS
29. GLOBAL OSTEOSYNTHESIS DEVICES MARKET , COMPANY PROFILE
29.1 STRYKER
29.1.1 COMPANY OVERVIEW
29.1.2 REVENUE ANALYSIS
29.1.3 GEOGRAPHIC PRESENCE
29.1.4 PRODUCT PORTFOLIO
29.1.5 RECENT DEVELOPMENTS
29.2 SMITH+NEPHEW
29.2.1 COMPANY OVERVIEW
29.2.2 REVENUE ANALYSIS
29.2.3 GEOGRAPHIC PRESENCE
29.2.4 PRODUCT PORTFOLIO
29.2.5 RECENT DEVELOPMENTS
29.3 B. BRAUN MEDICAL LTD.
29.3.1 COMPANY OVERVIEW
29.3.2 REVENUE ANALYSIS
29.3.3 GEOGRAPHIC PRESENCE
29.3.4 PRODUCT PORTFOLIO
29.3.5 RECENT DEVELOPMENTS
29.4 ZIMMER BIOMET.
29.4.1 COMPANY OVERVIEW
29.4.2 REVENUE ANALYSIS
29.4.3 GEOGRAPHIC PRESENCE
29.4.4 PRODUCT PORTFOLIO
29.4.5 RECENT DEVELOPMENTS
29.5 GLOBUS MEDICAL
29.5.1 COMPANY OVERVIEW
29.5.2 REVENUE ANALYSIS
29.5.3 GEOGRAPHIC PRESENCE
29.5.4 PRODUCT PORTFOLIO
29.5.5 RECENT DEVELOPMENTS
29.6 MICROPORT SCIENTIFIC CORPORATION
29.6.1 COMPANY OVERVIEW
29.6.2 REVENUE ANALYSIS
29.6.3 GEOGRAPHIC PRESENCE
29.6.4 PRODUCT PORTFOLIO
29.6.5 RECENT DEVELOPMENTS
29.7 SAS NEOSTEO
29.7.1 COMPANY OVERVIEW
29.7.2 REVENUE ANALYSIS
29.7.3 GEOGRAPHIC PRESENCE
29.7.4 PRODUCT PORTFOLIO
29.7.5 RECENT DEVELOPMENTS
29.8 PRECISION SPINE, INC.
29.8.1 COMPANY OVERVIEW
29.8.2 REVENUE ANALYSIS
29.8.3 GEOGRAPHIC PRESENCE
29.8.4 PRODUCT PORTFOLIO
29.8.5 RECENT DEVELOPMENTS
29.9 MEDTRONIC
29.9.1 COMPANY OVERVIEW
29.9.2 REVENUE ANALYSIS
29.9.3 GEOGRAPHIC PRESENCE
29.9.4 PRODUCT PORTFOLIO
29.9.5 RECENT DEVELOPMENTS
29.10 OLYMPUS
29.10.1 COMPANY OVERVIEW
29.10.2 REVENUE ANALYSIS
29.10.3 GEOGRAPHIC PRESENCE
29.10.4 PRODUCT PORTFOLIO
29.10.5 RECENT DEVELOPMENTS
29.11 ARTHREX, INC.
29.11.1 COMPANY OVERVIEW
29.11.2 REVENUE ANALYSIS
29.11.3 GEOGRAPHIC PRESENCE
29.11.4 PRODUCT PORTFOLIO
29.11.5 RECENT DEVELOPMENTS
29.12 LEPU MEDICAL TECHNOLOGY(BEIJING)CO.,LTD
29.12.1 COMPANY OVERVIEW
29.12.2 REVENUE ANALYSIS
29.12.3 GEOGRAPHIC PRESENCE
29.12.4 PRODUCT PORTFOLIO
29.12.5 RECENT DEVELOPMENTS
29.13 COOK
29.13.1 COMPANY OVERVIEW
29.13.2 REVENUE ANALYSIS
29.13.3 GEOGRAPHIC PRESENCE
29.13.4 PRODUCT PORTFOLIO
29.13.5 RECENT DEVELOPMENTS
29.14 EXACTECH, INC
29.14.1 COMPANY OVERVIEW
29.14.2 REVENUE ANALYSIS
29.14.3 GEOGRAPHIC PRESENCE
29.14.4 PRODUCT PORTFOLIO
29.14.5 RECENT DEVELOPMENTS
29.15 MEDARTIS AG
29.15.1 COMPANY OVERVIEW
29.15.2 REVENUE ANALYSIS
29.15.3 GEOGRAPHIC PRESENCE
29.15.4 PRODUCT PORTFOLIO
29.15.5 RECENT DEVELOPMENTS
29.16 DJO, LLC
29.16.1 COMPANY OVERVIEW
29.16.2 REVENUE ANALYSIS
29.16.3 GEOGRAPHIC PRESENCE
29.16.4 PRODUCT PORTFOLIO
29.16.5 RECENT DEVELOPMENTS
29.17 ORTHOFIX US LLC.
29.17.1 COMPANY OVERVIEW
29.17.2 REVENUE ANALYSIS
29.17.3 GEOGRAPHIC PRESENCE
29.17.4 PRODUCT PORTFOLIO
29.17.5 RECENT DEVELOPMENTS
29.18 BIOVENTUS.
29.18.1 COMPANY OVERVIEW
29.18.2 REVENUE ANALYSIS
29.18.3 GEOGRAPHIC PRESENCE
29.18.4 PRODUCT PORTFOLIO
29.18.5 RECENT DEVELOPMENTS
29.19 OSSATECHNICS
29.19.1 COMPANY OVERVIEW
29.19.2 REVENUE ANALYSIS
29.19.3 GEOGRAPHIC PRESENCE
29.19.4 PRODUCT PORTFOLIO
29.19.5 RECENT DEVELOPMENTS
29.20 NORMMED MEDICAL
29.20.1 COMPANY OVERVIEW
29.20.2 REVENUE ANALYSIS
29.20.3 GEOGRAPHIC PRESENCE
29.20.4 PRODUCT PORTFOLIO
29.20.5 RECENT DEVELOPMENTS
29.21 JOHNSON & JOHNSON
29.21.1 COMPANY OVERVIEW
29.21.2 REVENUE ANALYSIS
29.21.3 GEOGRAPHIC PRESENCE
29.21.4 PRODUCT PORTFOLIO
29.21.5 RECENT DEVELOPMENTS
29.22 LIFE SPINE, INC.
29.22.1 COMPANY OVERVIEW
29.22.2 REVENUE ANALYSIS
29.22.3 GEOGRAPHIC PRESENCE
29.22.4 PRODUCT PORTFOLIO
29.22.5 RECENT DEVELOPMENTS
29.23 MICROPORT
29.23.1 COMPANY OVERVIEW
29.23.2 REVENUE ANALYSIS
29.23.3 GEOGRAPHIC PRESENCE
29.23.4 PRODUCT PORTFOLIO
29.23.5 RECENT DEVELOPMENTS
29.24 PRECISION SPINE, INC
29.24.1 COMPANY OVERVIEW
29.24.2 REVENUE ANALYSIS
29.24.3 GEOGRAPHIC PRESENCE
29.24.4 PRODUCT PORTFOLIO
29.24.5 RECENT DEVELOPMENTS
29.25 ARTHREX
29.25.1 COMPANY OVERVIEW
29.25.2 REVENUE ANALYSIS
29.25.3 GEOGRAPHIC PRESENCE
29.25.4 PRODUCT PORTFOLIO
29.25.5 RECENT DEVELOPMENTS
29.26 LEPU MEDICAL TECHNOLOGY(BEIJING)CO.,LTD.
29.26.1 COMPANY OVERVIEW
29.26.2 REVENUE ANALYSIS
29.26.3 GEOGRAPHIC PRESENCE
29.26.4 PRODUCT PORTFOLIO
29.26.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
30. RELATED REPORTS
31. CONCLUSION
32. QUESTIONNAIRE
33. ABOUT DATA BRIDGE MARKET RESEARCH
